Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,650.5
-2.2 (-0.08%)

 

  • STI Straits Times Index
    2,650.5
    -2.2 (-0.08%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,604.5
    12.7 (0.80%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,796.9
    69.5 (0.27%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,397.0
    13.6 (0.40%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,641.3
    350.5 (1.57%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,068.9
    37.7 (0.75%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 603.3M
  • Value: 348.3M
  • Rise: 131
  • Fall: 129
  • Unch: 548

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.008+0.002
MDR0.001-
Clearbridge0.199+0.014
Singapore-eDev0.129-0.001
Adventus0.025-
Biolidics0.515+0.105
Medtecs Intl0.945+0.075
AsiaMedic0.033+0.002
Rex Intl0.178+0.001
CSC0.020+0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Biolidics BIOLIDICS LIMITED
Quotes 10 Minutes Delayed. Updated at 13 Jul 2020 10:37
Last (SGD): 0.530 Change: +0.120 High: 0.530 Remarks: -
Change (%): +29.27 Low: 0.445
Open 0.450 Yesterday's Close 0.410
Buy Price 0.525 Sell Price 0.530
Buy Volume ('000) 191.4 Sell Volume ('000) 781.9
Cumulative Volume ('000) 30,528.8 Cumulative Value 15,237,145
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.01847 Trailing EPS (SGD) e -0.01847 NAV (SGD) b 0.0418
PE a - Trailing PE f - Price / NAV b 12.6794
Dividend (SGD) d - Cash In Hand (SGD) g 0.0232 Issued & Paid-up Shares c 260,358,000
Dividend Yield (%) d - Price / Cash In Hand g 22.845 Treasury Shares h -
Beta - 75 Daysi 0.376 R-Squared - 75 Days(%)i 0.21 Market Cap (M) 137.990
Beta - 500 Daysi 0.494 R-Squared - 500 Days (%)i 1.19 Enterprise Value (M) 132.497
Piotroski F Score 2 Exchange Code 8YY Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 70.9946 6-Month VWAP 0.426 Free Float (%) 33.5
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Prof, Scientific & Technical Activities - Medical Specialties
Category Classification Medical & Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 02 Apr 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Biolidics SGX 137.990 - - 12.6794 -
Industry Medical & Biotechnology SGX 937.434 20.731 22.773 1.3171 2.046
Medical Specialties SGX 3,261.095 166.866 93.583 15.2127 0.325
Local Peer Top Glove SGX 21,336.876 175.066 99.624 19.4451 0.296
Local Peer Medtecs Intl SGX 521.940 333.333 333.508 6.0936 -
Local Peer UG Healthcare SGX 409.834 163.537 201.492 9.6491 0.122
Local Peer Yunnan Energy SGX 43.794 - - 0.9014 -
Local Peer Annica SGX 16.675 - - 3.3333 -
Global Peer ABBOTT LABORATORIES NYSE 164,573.804 44.892 46.503 5.4462 1.414
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 151,096.404 40.881 41.182 5.2907 0.201
Global Peer DANAHER CORP NYSE 130,120.460 52.282 47.541 4.4175 0.363
Global Peer MEDTRONIC PLC NYSE 121,803.453 25.434 25.434 2.4007 2.378
Global Peer BECTON DICKINSON & CO NYSE 72,958.990 67.430 80.175 3.4827 1.142
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,156.808 48.689 48.443 7.8946 -
Global Peer STRYKER CORP NYSE 66,678.153 32.011 30.812 5.0841 1.199
Global Peer BOSTON SCIENTIFIC CORP NYSE 49,548.356 10.542 11.558 3.5894 -
Global Peer BAXTER INTERNATIONAL INC NYSE 43,368.092 43.325 42.476 5.6330 0.992
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 43,029.033 32.943 32.943 3.0431 1.907
Other Global Peers EDWARDS LIFESCIENCES CORP (NYSE), DEXCOM INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), ALCON AG (NYSE), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), TOPGLOV (Bursa), INSULET CORPORATION (NASDAQ), HARTA (Bursa), FISHER & PAYKEL HEALTHCARE CORP (ASX), STERIS PLC (NYSE), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), WATERS CORP (NYSE), WEIGAO GROUP (HKEx), PERKINELMER INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), QUIDEL CORP (NASDAQ), QIAGEN NV (NYSE), MICROPORT (HKEx), DENTSPLY SIRONA INC (NASDAQ), COCHLEAR LTD (ASX), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), KANGJI MEDICAL (HKEx), GLOBUS MED INC (NYSE), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), SUPERMX (Bursa), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), AK MEDICAL (HKEx), NEVRO CORP (NYSE), WRIGHT MEDICAL GROUP NV (NASDAQ), ICU MEDICAL INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), PEIJIA-B (HKEx), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), INARI MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), EBOS GROUP (ASX), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), CAREDX INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), KDL MEDICAL (HKEx), SILK ROAD MEDICAL INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), LIFETECH SCI (HKEx), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), GENMARK DIAGNOSTICS INC (NASDAQ), ATRION CORP (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), VAPOTHERM INC (NYSE), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ZYNEX INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), INMODE LTD (NASDAQ), CIRC (HKEx), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), INOGEN INC (NASDAQ), VERICEL CORP (NASDAQ), NATUS MEDICAL INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), BIOLIFE SOLUTIONS INC (NASDAQ), QUOTIENT LTD (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), SI BONE INC (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), CORMEDIX INC (NYSE American), ESTABLISHMENT LABS HLDGS INC (NASDAQ), YESTAR HEALTH (HKEx), MCP INCOME OPPORTUNITIES TRUST (ASX), PW MEDTECH (HKEx), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), VIEWRAY INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), GOLDEN MEDITECH (HKEx), MEDICAL DEVELOPMENT INTL (ASX), STEREOTAXIS INC (NYSE American), PROFOUND MED CORP (NASDAQ), VINCENT MED (HKEx), IRADIMED CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ALPHA PRO TECH (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), MISONIX INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), INVACARE CORP (NYSE), BIOSIG TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), SIENTRA INC (NASDAQ), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), DERMTECH INC (NASDAQ), SOLITON INC (NASDAQ), MODERN DENTAL (HKEx), APYX MEDICAL CORPORATION (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), FONAR CORP (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), CELSION CORPORATION (NASDAQ), INTRICOM CORP (NASDAQ), BIOMERICA INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), CHEMBIO DIAGNOSTICS INC (NASDAQ), CYCLOPHARM LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), RESAPP HEALTH LIMITED (ASX), MILESTONE SCIENTIFIC INC (NYSE American), DAXOR CORP (NYSE American), SOMNOMED LIMITED (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), YUNNAN ENERGY (HKEx), NOVA EYE MEDICAL LIMITED (ASX), NEPHROS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CONFORMIS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), SDI LTD (ASX), LKL (Bursa), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), COMPUMEDICS (ASX), CLEARPOINT NEURO INC (NASDAQ), DIMERIX LTD (ASX), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), RESONANCE HEALTH LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), ZOSANO PHARMA CORP (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), KELFRED (HKEx), RESPIRI LTD (ASX), ONCOCYTE CORP (NYSE American), IMMUCELL CORP (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), NEURONETICS INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), MICRO-X LTD (ASX), SINTX TECHNOLOGIES INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), ELECTROCORE INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), IRIDEX CORP (NASDAQ), USCOM LTD (ASX), METALICITY LIMITED (ASX), NEUROTROPE INC (NASDAQ), LBT INNOVATIONS LTD (ASX), DARIOHEALTH CORP (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), CHF SOLUTIONS INC (NASDAQ), BIOLASE INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), LIFE HEALTHCARE (HKEx), AKERS BIOSCIENCES INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), CHECK-CAP LTD (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), XTANT MEDICAL HLDGS INC (NYSE American), AVINGER INC (NASDAQ), CARDIEX LTD (ASX), MYOS RENS TECHNOLOGY INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), OPTISCAN IMAGING (ASX), CYANOTECH CORP (NASDAQ), DIGIRAD CORP (NASDAQ), DYNATRONICS CORP (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), ADHERIUM LIMITED (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), ANALYTICA (ASX), CANCER GENETICS INC (NASDAQ), HUAKANG BIOMED (HKEx), NEUROMETRIX INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), ENDOLOGIX INC (NASDAQ), STHAI (SET), DORSAVI LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.215
+68.25 %
10 Days -+0.115
+27.71 %
20 Days -+0.125
+30.86 %
Medium Term Return 3 Months -+0.265
+100.00 %
6 Months -+0.300
+130.43 %
1 Year -+0.245
+85.96 %
Annualised Return Annualised --
+85.96 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.175 - 0.885 Change From 1 Year Low +0.355 % Change From 1 Year Low (%) +202.86
Change From 1 Year High -0.355 % Change From 1 Year High (%) -40.11
2 Years Range 0.175 - 0.885 Change From 2 Years Low +0.355 % Change From 2 Years Low (%) +202.86
Change From 2 Years High -0.355 % Change From 2 Years High (%) -40.11
5 Years Range 0.175 - 0.885 Change From 5 Years Low +0.355 % Change From 5 Years Low (%) +202.86
Change From 5 Years High -0.355 % Change From 5 Years High (%) -40.11
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company is a Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. The Company aspires to impact the lives of patients through the provision of diagnostic solutions in every cancer centre worldwide.The Company has developed the ClearCell FX1 System, a fully automated IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patients body.

IPO Performance

Listing Date 19 Dec 2018 Full Subscription Rate (x) -
No of Placement Shares (M) 27.50 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.235 First Week Close (SGD) 0.230
Current vs IPO Price (%) +89.29 First Day Gain (%) -16.07 First Week Gain (%) -17.86

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(5.32 MB)
Annual Report 2018 Dec 2018 Part 1(3.41 MB)
IPO Prospectus
IPO Prospectus 2018 Dec 2018 Part 1(2.88 MB)
Part 2(0.53 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
09 Jul 2020 0.320 0.425 0.320 0.410 61,642,900 0.3869
08 Jul 2020 0.315 0.320 0.305 0.310 4,456,300 0.3101
07 Jul 2020 0.315 0.325 0.310 0.315 2,425,800 0.3175
06 Jul 2020 0.315 0.325 0.310 0.315 3,006,800 0.3180
03 Jul 2020 0.320 0.335 0.310 0.320 5,627,200 0.3249
02 Jul 2020 0.290 0.340 0.285 0.315 12,685,000 0.3209
01 Jul 2020 0.310 0.310 0.285 0.295 7,369,900 0.2932
30 Jun 2020 0.315 0.330 0.300 0.305 4,428,300 0.3117
29 Jun 2020 0.295 0.350 0.280 0.320 17,626,300 0.3226
26 Jun 2020 0.415 0.420 0.405 0.410 2,937,900 0.4145
25 Jun 2020 0.410 0.420 0.405 0.415 3,261,800 0.4114
24 Jun 2020 0.420 0.420 0.410 0.410 2,950,900 0.4155
23 Jun 2020 0.415 0.430 0.410 0.420 6,563,800 0.4183
22 Jun 2020 0.420 0.425 0.405 0.410 2,576,300 0.4142
19 Jun 2020 0.420 0.440 0.420 0.420 19,236,300 0.4289
18 Jun 2020 0.400 0.420 0.400 0.415 6,871,800 0.4124
17 Jun 2020 0.410 0.415 0.400 0.410 2,820,500 0.4055
16 Jun 2020 0.420 0.420 0.405 0.410 2,730,100 0.4109
15 Jun 2020 0.425 0.435 0.405 0.410 4,888,700 0.4228
12 Jun 2020 0.395 0.420 0.390 0.415 5,791,400 0.4104
11 Jun 2020 0.430 0.445 0.405 0.405 8,323,700 0.4253
10 Jun 2020 0.395 0.435 0.390 0.430 11,909,200 0.4192
Summary
Current 2 Weeks
(26 Jun 2020 to 09 Jul 2020)
0.415 0.425 0.280 0.410 122,206,400 -
Previous 2 Weeks
(12 Jun 2020 to 25 Jun 2020)
0.395 0.425 0.280 0.415 57,691,600 -
4 Weeks from
(14 May 2020 to 11 Jun 2020)
0.450 0.460 0.280 0.405 119,694,400 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.